Prevalence and Associated Risk Factors of Age-Related Macular Degeneration in the Retina Clinic at a Tertiary Center in Makkah Province, Saudi Arabia: A Retrospective Record Review
- PMID: 37056542
- PMCID: PMC10089638
- DOI: 10.7759/cureus.36048
Prevalence and Associated Risk Factors of Age-Related Macular Degeneration in the Retina Clinic at a Tertiary Center in Makkah Province, Saudi Arabia: A Retrospective Record Review
Abstract
Background Age-related macular degeneration (AMD) is a progressive disease involving the macular region of the retina and is considered a significant cause of vision loss worldwide. With the increase in life expectancy in various countries, this problem has become more apparent. We retrospectively evaluated the prevalence of AMD among patients visiting the retina clinic at King Abdulaziz University Hospital (Jeddah, Makkah Province, Saudi Arabia) to identify the commonly associated risk factors of AMD. Methods The records of 3,067 individuals from 2017 to 2021 were reviewed. Of these, 1,935 were enrolled in the study. Results The prevalence of AMD among the patients was 4%. Regarding non-modifiable risk factors, age and having a family history of AMD showed a significant association (p = 0.001 and 0.043, respectively). However, sex and nationality were not significantly associated. As for modifiable risk factors, smoking and hypertension demonstrated a significant relationship (p < 0.001 and p = 0.002, respectively). However, the association with diabetes mellitus and dyslipidemia was not significant. Conclusion Our study shows that AMD is widely prevalent in Saudi Arabia and is associated with age, family history, smoking, and hypertension. Therefore, patients at risk of AMD must be screened and managed promptly before disease progression.
Keywords: age; epidemiology; retinal disorder; retrospective record review; smoking.
Copyright © 2023, Abusharkh et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
References
-
- Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study. GBD 2019 Blindness and Vision Impairment Collaborators; Vision Loss Expert Group of the Global Burden of Disease Study. Lancet Glob Health. 2021;9:144–160. - PMC - PubMed
-
- Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Wong WL, Su X, Li X, Cheung CM, Klein R, Cheng CY, Wong TY. Lancet Glob Health. 2014;2:106–116. - PubMed
-
- Age-related macular degeneration. Gheorghe A, Mahdi L, Musat O. https://pubmed.ncbi.nlm.nih.gov/26978865/ Rom J Ophthalmol. 2015;59:74–77. - PMC - PubMed
LinkOut - more resources
Full Text Sources
Research Materials